Page last updated: 2024-11-04

sulfinpyrazone and Cardiac Diseases

sulfinpyrazone has been researched along with Cardiac Diseases in 9 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Research Excerpts

ExcerptRelevanceReference
"Aspirin has been shown to reduce the number of transient ischemic attacks (TIA), stroke and death in patients with multiple TIA."3.75Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells. ( Turpie, AG, 1982)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19908 (88.89)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perrenoud, JJ1
Hilliker, KS1
Roth, RA1
Castaigne, A1
Palsky, E1
Benghozi, R1
Ledouarin, B1
Easton, JD1
Hart, RG1
Sherman, DG1
Kaste, M1
Turpie, AG1
Barnett, HJ1
Carter, G1
Gavin, JB1
Chamberlain, DA1
Klotz, H1
Prohaska, E1
Salmhofer, H1
Schmid, L1

Reviews

3 reviews available for sulfinpyrazone and Cardiac Diseases

ArticleYear
[News in cardiology].
    La Revue du praticien, 1983, Mar-21, Volume: 33, Issue:17

    Topics: Heart Diseases; Humans; Myocardial Infarction; Nifedipine; Sulfinpyrazone

1983
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Progress in clinical and biological research, 1982, Volume: 89

    Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary

1982
The pathophysiology of transient cerebral ischemic attacks.
    The Medical clinics of North America, 1979, Volume: 63, Issue:4

    Topics: Arteriosclerosis; Aspirin; Carotid Arteries; Cerebrovascular Disorders; Cholesterol; Embolism; Endoc

1979

Trials

2 trials available for sulfinpyrazone and Cardiac Diseases

ArticleYear
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Progress in clinical and biological research, 1982, Volume: 89

    Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary

1982
Overview of completed sudden death trials: European experience.
    Cardiology, 1987, Volume: 74 Suppl 2

    Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Clinical Tri

1987

Other Studies

5 other studies available for sulfinpyrazone and Cardiac Diseases

ArticleYear
[Role of medical treatment in the rehabilitation of the coronary patient].
    Revue medicale de la Suisse romande, 1981, Volume: 101, Issue:1

    Topics: Adrenergic beta-Antagonists; Anticoagulants; Aspirin; Coronary Disease; Heart Diseases; Humans; Myoc

1981
Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
    British journal of pharmacology, 1984, Volume: 82, Issue:2

    Topics: Animals; Body Weight; Cardiomegaly; Dexamethasone; Heart Diseases; Hydralazine; L-Lactate Dehydrogen

1984
Diagnosis and management of ischemic stroke. Part I.--Threatened stroke and its management.
    Current problems in cardiology, 1983, Volume: 8, Issue:5

    Topics: Anticoagulants; Arrhythmias, Cardiac; Aspirin; Brain Ischemia; Carotid Artery Thrombosis; Cerebral A

1983
Sulphinpyrazone reduces endocardial injury and mural thrombosis.
    Cardiovascular research, 1990, Volume: 24, Issue:4

    Topics: Animals; Endocardium; Endothelium; Heart Diseases; Lactates; Male; Microscopy, Electron, Scanning; M

1990
[Gout from the view of a special hospital for rheumatic patients].
    Wiener klinische Wochenschrift, 1971, Mar-19, Volume: 83, Issue:11

    Topics: Acute Disease; Adolescent; Adult; Aged; Austria; Child; Cholesterol; Colchicine; Colic; Diabetes Com

1971